Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Propylhexedrine |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Ergotoxine |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Tetryzoline (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Naphazoline (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Xylometazoline (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
forgiftning med vasokonstriktormiddel |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
1 |
Accidental ergot alkaloid poisoning |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Intentional ergot alkaloid poisoning |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
forgiftning med ergotalkaloid, uvist med hvilken hensigt |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
bivirkning af vasokonstriktor |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
1 |
Ergot compound adverse reaction |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
bivirkning af ergoloidmesylater |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Ergot alkaloid adverse reaction |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Dihydroergotamine mesylate adverse reaction |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Ergometrine adverse reaction (disorder) |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
allergi over for vasokonstriktor |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Ergot compound allergy |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
allergi over for ergoloidmesylater |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Allergy to ergot alkaloid (finding) |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
allergi over for dihydroergotaminmesylat |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Allergy to ergometrine |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
overdosis af vasokonstriktormiddel |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
1 |
Ergot alkaloid overdose |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Accidental ergot alkaloid overdose |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Intentional ergot alkaloid overdose |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
overdosis af ergotalkaloid, uvist med hvilken hensigt |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Co-dergocrine mesylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
ergoloidmesylater 1,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
ergoloidmesylater 4,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
menthol + benzoin inhalationstype |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Menthol+eucalyptus inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
menthol 35,55 mg inhalationspulver kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Product containing precisely ephedrine hydrochloride 5 milligram/1 milliliter conventional release nasal drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 10 mg/mL nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
ergotforbindelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Product containing dihydroergocornine and dihydroergocristine and dihydroergocryptine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
phenylephrin mod kongestion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Oxymetazoline (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
phenylephrin 0,125 % næsedråber, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
phenylephrin 0,25 % opløsning, næsedråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
phenylephrin 0,5 % opløsning, næsedråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
phenylephrin 1 % opløsning, næsedråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Ephedrine sulfate 2.5 mg/mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Poisoning by ergot alkaloid |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Sumatriptan (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Felypressin (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
vasokonstriktor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
præparat mod kongestion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
præparat mod næsekongestion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Co-dergocrine |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Tramazoline hydrochloride+dexamethasone isonicotinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
tramazolinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Frovatriptan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Ergot alkaloid |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Product containing tramazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
allergi over for vasokonstriktor |
Causative agent |
False |
Vasokonstriktor |
Inferred relationship |
Some |
1 |
Xylometazoline hydrochloride |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Naphazoline nitrate (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Naphazoline hydrochloride |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Oxymetazoline hydrochloride |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Tetryzoline hydrochloride |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Sumatriptan succinate |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Ornipressin |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Ephedrine (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Racephedrine |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Corbadrine |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Almotriptan malate |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Almotriptan (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Metaraminol (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Almotriptan hydrogen malate (substance) |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|
Metaraminol bitartrate |
Is a |
False |
Vasokonstriktor |
Inferred relationship |
Some |
|